Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

nephrocystin-2 Inhibitors

Nephrocystin-2 Inhibitors belong to a specialized chemical class that primarily targets a specific protein known as nephrocystin-2, which plays a critical role in the functioning of primary cilia within kidney cells. These inhibitors are designed to modulate the activity of nephrocystin-2, impacting cellular processes associated with ciliary function. Primary cilia are hair-like structures that protrude from the surface of many cell types, including kidney cells, and serve as crucial sensory organelles that detect various environmental cues and regulate intracellular signaling pathways. Nephrocystin-2, encoded by the NPHP2 gene, is an essential component of these primary cilia and is implicated in maintaining their structural integrity and function. Nephrocystin-2 Inhibitors are synthetic compounds or biologics specifically designed to interfere with the activity of nephrocystin-2. By binding to nephrocystin-2 or modulating its function, these inhibitors can potentially affect the assembly, maintenance, or signaling capabilities of primary cilia. Dysregulation of ciliary function has been associated with various genetic disorders, including nephronophthisis, a hereditary kidney disease characterized by cyst formation and progressive renal dysfunction.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

Everolimus is an mTOR (mammalian target of rapamycin) inhibitor. It may indirectly impact nephrocystin-2 through its effects on mTOR signaling pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Sirolimus is another mTOR inhibitor similar to everolimus that has been studied for its potential to slow the progression of PKD by modulating mTOR-related pathways.

13C6-Lys octreotide tri(trifluoroacetate)

83150-76-9 (unlabeled free base)sc-477942
500 µg
$388.00
(0)

Octreotide is a somatostatin analog that has been explored in some studies for its ability to inhibit cyst growth in PKD, although it does not directly target nephrocystin-2.